The synthesis and characterization of Co(II) and Ni(II) mixed ligand complexes are derived from isoniazid, 9-fluorenoneandoxalate. The metal complexes were characterized on the basis of elemental analysis, IR, UV-visible, CV, PXRD, and molar conductance analytical data, viz., all the metal complexes were suggested in an octahedral geometry, respectively. The mixed ligand complexes are formed in the 1:1:2:1 (M:L1:L2:L3) ratios, as found from the elemental analyses, and originate to have the formula [M(L1)(L2)2(L3)]. Where M = Co(II), Ni(II), L1 = isoniazid,L2= 9-fluorenone, and L3 = oxalate. The molar conductance data reveals that the complexes are non-electrolytes. The cyclic voltammogram of the Co(II) complex revealed that the quasi-reversible single electron transfer process and Ni(II) complex corresponding to a one-electron transfer process were observed during controlled potential electrolysis. IR spectra show that the ligands are coordinated to the metal ions through N and O donor sites of isoniazid-N, 9-fluorenone-O and oxalate-O. Magnetic moment values and UV-visible spectra were used to infer the coordinating of the geometrics of these complexes found to be octahedral. The PXRD patterns suggest that all the complexes are crystalline phases. The metal chelates have been screened for antimicrobial, antioxidant and anti-inflammatory activities, and our findings have been reported, explained and compared with some known antibiotics.
2,4-Dinitrophynylhydrazine and two thiocyanate ions in a (M:L1:L2) 1:2:2 molar ratio was synthesized in the complexes of Co(II) and Ni(II). The prepared compounds were identified through a C.H.N.S. analysis, conductivity measurements, powder X-ray diffraction (PXRD), the infrared spectrum, and a UV-visible spectrum analysis, in addition to the magnetic properties being measured. The measurements of the molar conductance implieda nonelectrolytic nature of compounds Co(II) and Ni(II). The magnetic susceptibility, as well as electronic spectra, represented all the metal complexesthroughoctahedral geometry, respectively. The PXRD patterns suggested that all the complexes were an orthorhombic system with unit cell parameters. The in-vitro biological activity of the ligand and the metal complexes were screened against the Gram-positive and negative pathogenic bacteria Staphylococcus aureus, Bacillus subtilis, Pseudomonas, aeruginosa and Escherichia coli, as well as the fungal species of Aspergillusniger and Candida albicans.Thus, the metal complexes showeda high efficiency of antimicrobial activity compared with the ligand. Furthermore, applications of the ligand, as well as the metal complexes, were tested for in-vitro antioxidant potential in aDPPH assay. The results showed that the activity of the metal complexes with the in-vitro antioxidant was more active than that of 2,4-dinitrophenylhydrazine(DNPH).
New Cobalt(II) and Nickel(II) metal complexes of 2-aminothiazole (ATZ) and benzoate ion (BEN) ligands were synthesized under microwave irradiation. The empirical formulae and the structure of the complexes have been deduced from CHN analysis, electrical conductance, magnetic moment, electronic (DRS method), Infra Red spectra, TGA analysis, cyclic voltammetry and powder-XRD techniques. The low electrical conductance values indicate that the complexes are non-electrolyte (1:0) type. The electronic spectra and the magnetic moment indicate the structures of the complexes are found to be octahedral geometry. Infra Red spectra illustrate that 2-aminothiazole and benzoate ion is bonded to the metal ion in a monodentate approach. The antifungal activities of ligands and their cobalt(II) and nickel(II) metal complexes were studied aligned with the few microorganisms by agar - well diffusion method at 100,200 and 400 conc. µg/ml concentration. The prepared cobalt(II) and nickel(II) metal complexes show prospective action against the tested fungi as compared to free 2-aminothiazole ligand. The free radical scavenging action of the prepared complexes and the ligand has been resolute by measuring their interface with the stable free radical DPPH. The complexes have larger antioxidant activity as compared to the free ligand. DNA-binding properties have been calculated by fluorescence-emissions method. The obtained results suggest that the complexes powerfully bind to DNA because of metal complexes are well-known to speed up the drug action and the capability of healing agent which can repeatedly be enhanced leading coordination with a metal ion.
Objectives: 2-aminobenzonitrile is used as the starting materials for the synthesis of many biologically active compounds. The main objective of the study was to synthesize, characterization and biological evaluation of a binuclear bridged Cr(III) complex containing 2-aminobenzonitrile (N,Ndonor) and octanoate ion (OC) as ligands. Methods: This study formulated, the required mole ratio of 2-aminobenzonitrile in methanol and sodium octanoate in ethanol were added to the chromium chloride in methanol followed by microwave irradiation for few seconds after each addition by using microwave oven and the precipitate was filtered off, washed with 1:1 ethanol: water and characterized by various spectral studies and biological significance. Results: The resulted complex was investigated by the help of elemental analysis, molar conductance, magnetic moment, electronic spectra, FT-IR, cyclic voltammetry, thermal analysis and powder-XRD techniques. The spectral data's indicates that the geometry of the complex is octahedral. The antimicrobial activities of ligands and their Cr(III) complex were studied by agar-well diffusion method. The free radical scavenging activity of the complex and the ligands has been determined by measuring their interaction with the stable free radical DPPH. DNA-binding properties have been studied by fluorescence-emission method. Conclusion: The formulated Cr(III) complex showed moderate and potential activity against the tested bacteria, enhanced activity against the fungi and larger antioxidant activity as compared to the free ligands. The DNA binding study result suggests that the complex strongly binds to DNA.
A new bidentate Schiff base (E)-N′[(E)-3-phenylallylidene]benzene-1,2-diamine derived from the
condensation of o-phenylenediamine and cinnamaldehyde and its Mn(II) and Hg(II) complexes were
synthesized and characterized by elemental analysis, molar conductance, magnetic moment, electronic
spectra, IR, far-IR and NMR (1H & 13C) spectral studies. The elemental analysis and these metal
proposed the metal:ligand stoichiometry and molecular formulae of the metal complexes. The molar
conductance and electrochemical property indicates monomeric, neutral nature and redox properties
of the metal complexes. The UV-visible spectral study supports the octahedral geometry for Mn(II)
complex and square planar geometry for Hg(II) complex and further confirmed by magnetic moment.
IR spectral data examined the coordination mode but far-IR is useful to identify the metal-ligand
vibrations. The geometry, magnetic property and unsymmetrical nature of these metal complexes
corroborated by NMR (1H & 13C) spectra. The DFT of Mn(II) complex studied and the structure
optimized by B3LYP/Lan L2DZ using Gaussian 09W. Quantum chemical calculations were done by
Mullikan population analysis, HOMO-LUMO and molecular electrostatic potential. The in vitro
biological screening effects of the investigated complexes were tested against some bacteria and fungus
by agar-well diffusion method. The results indicated that Mn(II) and Hg(II) complexes exhibit potentially
active than the Schiff base which was further confirmed by pharmacokinetics study. The antioxidant
activity of Schiff base and its Mn(II) complex was examined by radical scavenging DPPH method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.